Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Domo, Inc. - Class B Common Stock (NQ:DOMO)

13.76 -0.10 (-0.75%)
Streaming Delayed Price Updated: 11:27 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Domo, Inc. - Class B Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Domo Announces 2023 Domo Community Ovation Awards Finalists
From Domo
Via Business Wire
Domopalooza 2023 Unveils Full Lineup of Industry Experts and Customer Speakers
From Domo
Via Business Wire
Expert Ratings for Domo
 
Via Benzinga
Domo (DOMO) Q4 2023 Earnings Call Transcript
DOMO earnings call for the period ending December 31, 2022. 
Via The Motley Fool
A Preview Of Domo's Earnings
 
Via Benzinga
Where Domo Stands With Analysts
 
Via Benzinga
12 Information Technology Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Domo Named a Winner in the 2022-2023 Cloud Awards for Cloud BI and Analytics
From Domo, Inc.
Via Business Wire
12 Information Technology Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Domo Announces Fourth Quarter and Fiscal 2023 Financial Results
From Domo, Inc.
Via Business Wire
Where Domo Stands With Analysts
 
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
Domo Announces CEO Transition: John Mellor Steps Down as CEO, Succeeded by Domo Founder Josh James
From Domo, Inc.
Via Business Wire
Domo Executives to Participate in Upcoming Investor Conferences
From Domo, Inc.
Via Business Wire
Domo Named a Winner of Five Dresner Advisory Services 2022 Technology Innovation Awards
From Domo
Via Business Wire
A New Global Report from Domo Shows More than 60% of Workers are “Sleepworking”
From Domo
Via Business Wire
Domo Announces Timing of its Fourth Quarter and Full-Year Fiscal 2023 Earnings Conference Call
From Domo
Via Business Wire
12 Information Technology Stocks Moving In Friday's Intraday Session
 
Via Benzinga
11 Information Technology Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday saw 23 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
 
Via Benzinga
Domo Announces Domopalooza 2023, its Award-Winning Annual Customer Event
From Domo
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
Domo Executives to Participate in the 25th Annual Needham Growth Conference
From Domo
Via Business Wire
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Domo Ranked #1 Vendor in Dresner Advisory Services' 2022 Analytical Platforms Market Study
From Domo, Inc.
Via Business Wire
Domo Named a Best Company to Work for by Utah Business Magazine for Eleventh Consecutive Year
From Domo, Inc.
Via Business Wire
Better Cloud Software Stock: Snowflake vs. Domo
Which silo-busting cloud play is a better long-term investment? 
Via The Motley Fool
MATTER Partners with Domo to Support Development of Innovation Hub Program to Help Students in Need
From Domo, Inc.
Via Business Wire
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.